Previous 10 | Next 10 |
2024-02-04 06:14:22 ET Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. Introduction The D...
2024-02-01 15:08:19 ET More on CVS Health, Humana, etc. UnitedHealth: Rejoice When The Market Turns Fearful (Upgrade) Humana, We Have A Problem Humana: The $300 Level Could Get Taken Out In The Near Future Humana on track for worst monthly drop in a decade on...
2024-01-30 13:43:22 ET Summary Elevance Health reported Q4 earnings that beat expectations for both EPS and revenue. The company exceeded its 2023 guidance but disappointed with its 2024 guidance, predicting flat to low single-digit revenue growth. Potential risks to Elevance'...
2024-01-30 01:35:37 ET More on Elevance Health Elevance Health: Time To Buy This Incredible Dividend Growth Stock Elevance Health, Inc. (ELV) Q4 2023 Earnings Call Transcript Elevance Health, Inc. 2023 Q4 - Results - Earnings Call Presentation Elevance Health...
2024-01-28 11:52:19 ET Summary Baillie Gifford's 13F portfolio value increased from ~$110B to ~$126B this quarter. The top three holdings are MercadoLibre, NVIDIA, and Amazon.com, accounting for ~17% of the portfolio. Baillie Gifford increased stakes in PDD Holdings, Shopify, ...
2024-01-26 09:03:26 ET Summary Elevance Health rewarded shareholders with a 10.1% hike in its quarterly dividend per share. The managed care company's operating revenue and adjusted diluted EPS climbed in the fourth quarter. Elevance Health enjoys an A credit rating from S&...
2024-01-26 07:16:34 ET More on Cigna, CVS Health, etc. Humana: The $300 Level Could Get Taken Out In The Near Future Humana Inc. (HUM) Q4 2023 Earnings Call Transcript CVS Health: Back In The Buy Column Humana gets downgrade at Deutsche Bank as stock nears fo...
2024-01-25 12:15:01 ET RBC Capital analyst issues OUTPERFORM recommendation for ELV on January 25, 2024 12:01PM ET. The previous analyst recommendation was Outperform. ELV was trading at $467.73 at issue of the analyst recommendation. The overall analyst consensus : BUY....
2024-01-25 07:33:46 ET Summary I sold my entire position in Lowe's shares due to concerns about the physical retail industry and Lowe's slowing growth. I used the proceeds to invest in three other blue-chip dividend growers with stronger upside and income-oriented potential. I...
2024-01-25 07:10:45 ET Humana ( NYSE: HUM ) shares plunged 16% premarket on Thursday after the U.S. health insurer issued an annual earnings forecast that was far below Wall Street estimates.... Read the full article on Seeking Alpha For further details see: Huma...
News, Short Squeeze, Breakout and More Instantly...
Elevance Health Inc Com Company Name:
ELV Stock Symbol:
NYSE Market:
Elevance Health Inc Com Website:
2024-07-17 12:00:27 ET Image source: The Motley Fool. Elevance Health (NYSE: ELV) Q2 2024 Earnings Call Jul 17, 2024 , 8:30 a.m. ET Operator Continue reading For further details see: Elevance Health (ELV) Q2 2024 Earnings Call Transcript
Assa Abloy AB ADR (ASAZY) is expected to report for Q2 2024 First Horizon Corporation (FHN) is expected to report $0.37 for Q2 2024 Community Trust Bancorp Inc. (CTBI) is expected to report $1.03 for Q2 2024 Cohen & Steers Inc (CNS) is expected to report for Q2 2024 First Indu...
2Q 2024 operating revenue of $43.2 billion 2Q 2024 adjusted operating gain 1 of $2.8 billion 2Q 2024 diluted EPS 2 of $9.85, up 26%; adjusted diluted EPS 1 of $10.12, up 12% 3Q 2024 dividend of $1.63 per share declared to shareholders Elevance Healt...